189 filings
Page 9 of 10
6-K
zu612ap 6djxa
16 May 18
Zealand Pharma — Interim report for the first quarter of 2018
12:04pm
6-K
q2tmj
27 Apr 18
Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018
11:04am
6-K
r11zf5ye
26 Apr 18
Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome
10:55am
6-K
nmo8f69qi1qr30ujhko9
25 Apr 18
Current report (foreign)
3:55pm
6-K
d75jnfb 4vgcy
19 Apr 18
Zealand’s Annual General Meeting in 2018
12:00am
6-K
8yp71p299g65x9 v98
22 Mar 18
Zealand Pharma convenes its Annual General Meeting 2018
12:00am
6-K
9paunpxii
20 Mar 18
Current report (foreign)
12:00am
6-K
wvyzd3dmr
7 Mar 18
Zealand Pharma 2017 full-year results in line with guidance – considerable progress in the clinical portfolio
12:00am
6-K
edififvkw
7 Feb 18
Zealand reports royalty revenue for the fourth quarter of 2017
12:00am
6-K
x3uzoo1 io1l0yv
23 Jan 18
Current report (foreign)
12:00am
6-K
7pq gfqtk
23 Jan 18
Current report (foreign)
12:00am
6-K
75jwg2glh6kw5ep
22 Jan 18
Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018
12:00am
6-K
51rhib 382
16 Jan 18
Current report (foreign)
12:00am
6-K
uivtld 6q66
3 Jan 18
Current report (foreign)
12:00am
6-K
n9en1i8
21 Dec 17
Zealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLetTM
12:00am
6-K
36f1hik6
7 Dec 17
Zealand Pharma initiates the pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes
12:00am
6-K
npawyleuc8n1nfix9
1 Dec 17
Employee elected board member change in Zealand Pharma
12:00am
6-K
xnrh uf0ludb8epx4mq
20 Nov 17
Current report (foreign)
12:00am
6-K
k175y180evpm m0rrhqk
8 Nov 17
Interim report for the first nine months of 2017
12:00am
6-K
dn8jgls7hbpd
2 Nov 17
Zealand reports royalty revenue for the third quarter of 2017
12:00am